Interpharm Holdings, Inc.

IPAH · OTC
Analyze with AI
6/30/2007
6/30/2006
6/30/2005
6/30/2004
Operating Activities
Net Income-$14,058-$3,790-$149$3,123
Dep. & Amort.$2,554$1,534$1,248$886
Deferred Tax$195-$1,678-$78$1,999
Stock-Based Comp.$0$0$0$0
Change in WC-$7,020$3,568-$3,365-$3,920
Other Non-Cash$4,224$1,167-$9$38
Operating Cash Flow-$14,105$801-$2,353$2,126
Investing Activities
PP&E Inv.-$8,003-$6,833-$8,112-$4,424
Net Acquisitions$0$0-$1,023$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$46$1,524
Other Inv. Act.-$293-$1,309-$561-$160
Investing Cash Flow-$8,296-$8,142-$9,650-$3,060
Financing Activities
Debt Repay.$10,753-$1,521$9,206-$2,102
Stock Issued$10,386$10,405$627$3,520
Stock Repurch.$0$0-$0$0
Dividends Paid-$124-$248-$179$0
Other Fin. Act.$20-$393$0$64
Financing Cash Flow$21,035$8,243$9,654$1,482
Forex Effect$0$0$0$0
Net Chg. in Cash-$1,366$902-$2,349$549
Supplemental Information
Beg. Cash$1,438$536$2,885$2,336
End Cash$72$1,438$536$2,885
Free Cash Flow-$22,108-$6,032-$10,465-$2,298
Interpharm Holdings, Inc. (IPAH) Financial Statements & Key Stats | AlphaPilot